-
Drug Manufacturers Most Active: Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZN)
Pfizer Inc. (NYSE:PFE)’s $106 billion bid for AstraZeneca Plc (AZN) faces increased resistance as the unwilling target’s chairman listed the reasons the offer was rejected and British lawmakers began efforts to block the buyout attempt. Shares of Pfizer Inc. (NYSE:PFE) closed at $31.28 in last trading session. Yesterday share price of the company was traded…
-
Drug Manufacturer Most Active Stocks: Pfizer Inc. (NYSE:PFE), Eli Lilly (NYSE:LLY), Merck & Co (NYSE:MRK), AbbVie Inc (NYSE:ABBV)
Actavis PLC and Pfizer Inc. (NYSE:PFE) said they settled all patent litigation over the generic version of painkiller Celebrex, which may allow Actavis to start marketing its version before the end of the year. Shares of Pfizer Inc. (NYSE:PFE)closed at $30.71 in last trading session. Yesterday share price of the company was traded in the…
-
Drug Most Active Stocks: GW Pharmaceuticals (NASDAQ:GWPH), Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY), AstraZeneca (NYSE:AZN)
Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), which develops cannabis-based drugs, are climbing after Morgan Stanley initiated coverage of the stock with an Overweight rating and $103 price target in a note to investors earlier today. WHAT’S NEW: A small but growing set of data suggests that GW’s epilepsy treatments can help patients with refractory…
-
Hot Stocks – Johnson & Johnson (JNJ), Pfizer (PFE), Merck (MRK), Abbott Laboratories, Bristol-Myers (BMY), Eli Lilly
Johnson & Johnson (NYSE:JNJ) continues to fight an effort by plaintiffs in Risperdal lawsuits to procure the release of certain documents produced during discovery as part of a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports. Johnson & Johnson (NYSE:JNJ) shares fell -0.03% to $92.48 in current session.…